Back to Search
LEON STRAUSS, MD
MD
Ophthalmology Physician
NPI: 1811971716Individual
Specialties, Licenses & Credentials
Ophthalmology PhysicianPrimary
Ophthalmology
Code: 207W00000X
D0034104(MD)
Research & Publications (20)
Human circulating CD4+CD25highFoxp3+ regulatory T cells kill autologous CD8+ but not CD4+ responder cells by Fas-mediated apoptosis.
PMID 19155494·J Immunol·2009
4-observational
Quantification of pulmonary blood flow (PBF): validation of perfusion MRI and nonlinear contrast agent (CA) dose correction with H(2)15O positron emission tomography (PET).
PMID 19488992·Magn Reson Med·2009
4-observational
Early effects of FOLFOX treatment of colorectal tumour in an animal model: assessment of changes in gene expression and FDG kinetics.
PMID 19280186·Eur J Nucl Med Mol Imaging·2009
7-preclinical
Positron emission tomography (PET) and macromolecular delivery in vivo.
PMID 19085122·Methods Mol Biol·2009
8-other
Increased frequency and suppression by regulatory T cells in patients with acute myelogenous leukemia.
PMID 19417016·Clin Cancer Res·2009
8-other
Comment on M. Guillot-Delost et al. (2008;10:834-846): Clinical-grade preparation of human natural regulatory T cells encoding the thymidine kinase suicide gene as a safety gene.
PMID 19172613·J Gene Med·2009
8-other
Increased exposure to estrogens disturbs maturation, steroidogenesis, and cholesterol homeostasis via estrogen receptor alpha in adult mouse Leydig cells.
PMID 19196801·Endocrinology·2009
7-preclinical
Tumor-derived microvesicles in sera of patients with head and neck cancer and their role in tumor progression.
PMID 19073006·Head Neck·2009
8-other
Differential responses of human regulatory T cells (Treg) and effector T cells to rapamycin.
PMID 19543393·PLoS One·2009
8-other
Early prediction of therapy outcome in patients with high-risk soft tissue sarcoma using positron emission tomography.
PMID 18322413·Onkologie·2008
2-rct
Intermittent target inhibition with dasatinib 100 mg once daily preserves efficacy and improves tolerability in imatinib-resistant and -intolerant chronic-phase chronic myeloid leukemia.
PMID 18541900·J Clin Oncol·2008
3-trial
T regulatory type 1 cells in squamous cell carcinoma of the head and neck: mechanisms of suppression and expansion in advanced disease.
PMID 18559587·Clin Cancer Res·2008
8-other
Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma.
PMID 17729249·Pediatr Blood Cancer·2008
3-trial
Expression of ICOS on human melanoma-infiltrating CD4+CD25highFoxp3+ T regulatory cells: implications and impact on tumor-mediated immune suppression.
PMID 18292519·J Immunol·2008
8-other
Impact of angiogenesis-related gene expression on the tracer kinetics of 18F-FDG in colorectal tumors.
PMID 18632818·J Nucl Med·2008
8-other
Placenta defects and embryonic lethality resulting from disruption of mouse hydroxysteroid (17-beta) dehydrogenase 2 gene.
PMID 18048640·Mol Endocrinol·2008
7-preclinical
The role of 18F-FLT in cancer imaging: does it really reflect proliferation?
PMID 18183395·Eur J Nucl Med Mol Imaging·2008
7-preclinical
Can PET-CT with FDG replace contrast enhanced CT for imaging of liver metastases?
PMID 17938920·Eur J Nucl Med Mol Imaging·2007
8-other
The frequency and suppressor function of CD4+CD25highFoxp3+ T cells in the circulation of patients with squamous cell carcinoma of the head and neck.
PMID 17975141·Clin Cancer Res·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1777 REISTERSTOWN RD, SUITE 380 EAST
BALTIMORE, MD 21208 - Phone
- (410) 484-5550
Quick Facts
- NPI
- 1811971716
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile